<- Go Home
Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Market Cap
CHF 1.8B
Volume
50.1K
Cash and Equivalents
CHF 255.7M
EBITDA
CHF 104.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CHF 319.0M
Profit Margin
35.19%
52 Week High
CHF 248.00
52 Week Low
CHF 131.50
Dividend
2.17%
Price / Book Value
1.37
Price / Earnings
27.96
Price / Tangible Book Value
5.20
Enterprise Value
CHF 1.7B
Enterprise Value / EBITDA
14.35
Operating Income
CHF 66.9M
Return on Equity
4.70%
Return on Assets
2.06
Cash and Short Term Investments
CHF 397.0M
Debt
CHF 322.0M
Equity
CHF 1.3B
Revenue
CHF 906.6M
Unlevered FCF
CHF 119.8M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium